Percutaneous ethanol injection for benign cystic and mixed thyroid nodules

Autor: Sule Temizkan, Aysenur Ozderya, Naile Gokkaya, Kadriye Aydin
Rok vydání: 2018
Předmět:
Adult
Male
Thyroid nodules
medicine.medical_specialty
Injections
Subcutaneous

Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Biopsy
Fine-Needle

Thyrotropin
030209 endocrinology & metabolism
macromolecular substances
Iodide Peroxidase
Gastroenterology
Thyroid function tests
030218 nuclear medicine & medical imaging
03 medical and health sciences
Endocrinology
0302 clinical medicine
Cytology
Internal medicine
Aspiration biopsy
Biopsy
Internal Medicine
medicine
Humans
Volume reduction
Thyroid Nodule
Autoantibodies
030219 obstetrics & reproductive medicine
Ethanol
medicine.diagnostic_test
Cysts
business.industry
technology
industry
and agriculture

Nodule (medicine)
General Medicine
Middle Aged
medicine.disease
Anti-thyroid autoantibodies
030220 oncology & carcinogenesis
Female
medicine.symptom
Percutaneous ethanol injection
business
Zdroj: Endocrine Abstracts.
ISSN: 1479-6848
DOI: 10.1530/endoabs.56.p1023
Popis: We aimed to determine the effect of percutaneous ethanol injection (PEI) on volume of cystic and mixed thyroid nodules, thyroid function tests (TFTs), antibody titers, and cytologic changes for 1 year.Fifty-five nodules from 53 patients with cystic and mixed properties treated with PEI were included. Nodule volumes, TFTs, and thyroid autoantibodies were analyzed at baseline, 6 months, and 12 months. Fine-needle aspiration biopsy (FNAB) was performed to PEI-treated nodules in the 12th month. Thyroid nodules were classified into three groups by structural properties (purely cystic, predominantly cystic, predominantly solid).PEI caused a volume reduction of 80.7% at 6 months and 82.1% at 12 months, without any serious complications. PEI was repeated 1.4 ± 0.4 times with a mean total ethanol amount of 3.6 ± 3.1 mL. Volume reduction in the purely cystic nodules in the 6th and 12th months after PEI was greater than the volume reductions in predominantly cystic and predominantly solid nodules. We found that smaller nodules had greater volume reductions after PEI in the 12th month. During the study, patients remained euthyroid. Antithyroglobulin levels were decreased at 12 months. None of the FNAB results were compatible with a malignant or suspicious for malignancy cytology at the 12th month.PEI is an effective means of treatment for benign cystic and mixed thyroid nodules, without any serious side effects. We can also assume that PEI is not a trigger for autoimmunity and malignancy development over the short term.anti-TG = anti-thyroglobulin; anti-TPO = anti-thyroperoxidase; AUS = atypia of unknown significance; CV = coefficient of variation; FNAB = fine-needle aspiration biopsy; fT3 = free triiodothyronine; fT4 = free thyroxine; PEI = percutaneous ethanol injection; TFT = thyroid function test; TSH = thyroid-stimulating hormone; US = ultrasonography.
Databáze: OpenAIRE